SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

77,540.83 3.11
( 0.00%)

Global Indices

Nasdaq

53,294.39 514.18
(0.97%)

Dow Jones

7,693.51 31.35
(0.41%)

Hang Seng

65,893.13 -323.66
(-0.49%)

Nikkei 225

10,809.01 60.85
(0.57%)

Forex

USD-INR

95.67 0.05
(0.05%)

EUR-INR

111.76 0.57
(0.51%)

GBP-INR

130.35 0.55
(0.42%)

JPY-INR

0.60 0.00
(0.11%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Industry :

BSE Code

ISIN Demat

Book Value()

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

EPS(TTM)

Face Value()

Div & Yield %

Back

royal india corporation ltd

Alembic Pharmaceuticals consolidated net profit rises 12.11% in the June 2026 quarter

Aug 04,2026

Net profit of Alembic Pharmaceuticals rose 12.11% to Rs 173.07 crore in the quarter ended June 2026 as against Rs 154.38 crore during the previous quarter ended June 2025. Sales rose 25.66% to Rs 2149.77 crore in the quarter ended June 2026 as against Rs 1710.72 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	2149.77	1710.72	26
OPM %	15.44	16.42	-
PBDT	319.57	263.88	21
PBT	221.86	190.11	17
NP	173.07	154.38	12

77,540.83 3.11 ( 0.00%)

53,294.39 514.18 (0.97%)

7,693.51 31.35 (0.41%)

65,893.13 -323.66 (-0.49%)

10,809.01 60.85 (0.57%)

95.67 0.05 (0.05%)

111.76 0.57 (0.51%)

130.35 0.55 (0.42%)

0.60 0.00 (0.11%)